Press Releases
Immunomic to Present at the 2019 BIO CEO & Investor Conference
Press ReleasesJanuary 24, 2019 04:05 PM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. announced today that its’ founder and CEO, William Hearl, Ph.D., will present an overview of theRead moreImmunomic Therapeutics to Present at the 2018 World Vaccine & Immunotherapy Congress
Press Press ReleasesNovember 15, 2018 06:15 AM Eastern Standard Time SAN DIEGO--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI) announced today that the company will present and participate at the 2018 World Vaccine & ImmunotherapyRead moreImmunomic Therapeutics Scientist to Present at the Society for NeuroOncology 2018 Annual Meeting
Press Press ReleasesNovember 07, 2018 06:00 AM Eastern Standard Time NEW ORLEANS--(BUSINESS WIRE)--On Friday, November 16, Immunomic Therapeutics Inc. (ITI) Scientist Amit Adhikara will present at the Society for NeuroOncology 2018 AnnualRead more- Press Press ReleasesImmunomic Therapeutics Senior Director of Corporate Development to Present at Precision Lung Cancer World R&D Summit Discussion of lysosomal targeting technology as applied in cancer immunotherapy October 26, 2018 07:30Read more
Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference
Press Press ReleasesImmunomic Therapeutics CEO to Present at NYC Oncology Investor Conference To Discuss UNITE Technology Application in Oncology October 23, 2018 07:00 AM Eastern Daylight Time NEW YORK--(BUSINESS WIRE)--Immunomic Therapeutics,Read moreImmunomic Therapeutics CEO to Join Panel at 18th Annual Biotech in Europe Forum
Press ReleasesPanel to Highlight Advanced Therapeutics for Oncology October 03, 2018 12:00 AM Eastern Daylight Time BASEL, Switzerland--(BUSINESS WIRE)--Tomorrow, William Hearl, Ph.D., Chief Executive Officer (CEO) of Immunomic Therapeutics, Inc., willRead moreICYMI…Immunomic Therapeutics Presents at the 2018 BIO Investor Forum…Watch webcast here
Featured Past Events Press ReleasesImmunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company presented at the 2018 BIO Investor Forum held in San Francisco, CA on October 17-18. William Hearl, Ph.D., Immunomic’s FounderRead moreImmunomic Therapeutics CEO at Outsourcing in Clinical Trials Mid-Atlantic
Press ReleasesITI Founder & CEO will discuss new developments in cancer immunotherapy October 01, 2018 05:02 PM Eastern Daylight Time ROCKVILLE, Md. (BUSINESSWIRE)--Bill Hearl, Ph.D., Founder and Chief Executive Officer (CEO)Read more- Press ReleasesImmunomic Therapeutics Appoints Recognized Immuno-Oncology Expert, Dr. Richard Ambinder, to its Scientific Advisory Board September 10, 2018 06:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privatelyRead more
- Press Press ReleasesJanuary 23, 2018 11:24 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Tomorrow, Immunomic Therapeutics, Inc. Senior Director of Corporate Development Sia Anagnostou will present at Phacilitate’s Immuno-Oncology Frontiers World in Miami.Read more
- Featured Highlights Press ReleasesDecember 13, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, is pleased to welcome Drew Pardoll, MD, Ph.D., Director ofRead more
Dr. Duane Mitchell Reports Findings of Study Aimed at Aggressive Brain Cancer
Highlights Press ReleasesCancer Vaccination Approach Incorporates Immunomic Therapeutics' LAMP-Vax Technology with CMV Technology November 22, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Last week results from a study conducted by investigatorsRead more